WebBiotheranostics, Inc. is a commercial-stage molecular diagnostics company that develops and provides diagnostic, prognostic and predictive tests that support physicians in the treatment of cancer patients. The company is based in San Diego, CA and offers testing se rvices through its CLIA-certified, CAP-accredited laboratory that is directly ... WebJan 5, 2024 · Biotheranostics is a leader in the development of evidence-based biomarkers to address unmet medical needs, and the company has set the foundation …
Did you know?
WebBiotheranostics, Inc. has been acquired by Hologic. Hologic is an innovative medical technology company whose purpose is to enable healthier lives everywhere, every day. … WebOct 29, 2024 · San Diego, CA, Oct. 29, 2024 (GLOBE NEWSWIRE) -- Biotheranostics announces the publication of results from the IDEAL study in Clinical Cancer Research which reports novel findings of the Breast ...
WebFeb 21, 2024 · This report contains market sizing and forecasts for this important area of molecular testing, including the following global market information: Global Molecular Cancer Diagnostics Market, 2024 ... WebJan 8, 2024 · Hologic, Inc. (. HOLX Quick Quote. HOLX - Free Report) recently announced its plans to acquire Biotheranostics, Inc., a privately held commercial-stage company …
WebJun 29, 2024 · The Breast Cancer Index test, made by Biotheranostics, analyzes the activity of 11 genes to help predict the risk of early-stage, hormone-receptor-positive breast cancer coming back 5 to 10 years after diagnosis. The test can help women and their doctors decide if extending hormonal therapy 5 more years (for a total of 10 years of … Web2 days ago · All quotes are in local exchange time. Real-time last sale data for U.S. stock quotes reflect trades reported through Nasdaq only. Intraday data delayed at least 15 minutes or per exchange ...
WebDec 10, 2024 · San Diego, CA, Dec. 10, 2024 (GLOBE NEWSWIRE) -- Biotheranostics, Inc. announced today that several abstracts featuring updates on ongoing resea...
WebJan 5, 2024 · – Transaction Accelerates Hologic’s Entry into Oncology Growth Market, Provides New Lab Capabilities – – Hologic’s Commercial Resources, Expertise in … china custom delivery in shanghaiWebCompany profile page for BioTheranostics Inc including stock price, company news, press releases, executives, board members, and contact information china custom declaration formWebJan 5, 2024 · Hologic, Inc. (Nasdaq: HOLX), a global leader in women's health, announced today that it has agreed to acquire Biotheranostics, Inc., a privately held, commercial … grafton legal aidWebMar 11, 2024 · News for Hologic Stock (HOLX) Hologic Stock Sees Composite Rating Climb To Lofty 96. Investors Business Daily • 03/17/21. Top-Rated Stocks: Hologic Sees Composite Rating Climb To 96 ... Hologic Completes Acquisition of Biotheranostics, Enabling Entry into Growing Oncology Market. Business Wire • 02/22/21. Is Hologic … grafton lawn mower serviceWebFeb 22, 2024 · Biotheranostics also developed and markets the CancerTYPE ID test, which provides a molecular diagnosis for patients with uncertain or unknown cancers. In … grafton levee wallWeb(See HOLX stock analysis on TipRanks) Following the deal, Needham analyst Michael Matson said, “HOLX is a leader in the infectious disease testing market and we believe … china custom entry mats factoryWebMar 30, 2024 · Dirix LY, Takacs I, Jerusalem G, Nikolinakos P, Arkenau HT, Forero-Torres A, Boccia R, Lippman ME, Somer R, Smakal M, Emens LA, Hrinczenko B, Edenfield W, Gurtler J, von Heydebreck A, Grote HJ, Chin K, Hamilton EP. Avelumab, an anti-PD-L1 antibody, in patients with locally advanced or metastatic breast cancer: a phase 1b … china custom design sports towel